Nektar Therapeutics ( NKTR) - Key Metrics
NKTR Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.31 | -$1.23 | -$2.29 | -$2.30 |
| 2026Q1 | $0.44 | -$1.82 | -$1.79 | -$1.79 |
| 2025Q4 | $1.07 | -$1.78 | -$3.20 | -$3.20 |
| 2025Q3 | $0.84 | -$2.52 | -$3.46 | -$3.47 |
| 2025Q2 | $0.79 | -$2.95 | -$3.25 | -$3.25 |
NKTR Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -14.19 |
| 2026Q1 | 0% | -9.88 |
| 2025Q4 | 0% | -5.94 |
| 2025Q3 | 0% | -7.61 |
| 2025Q2 | 0% | -2.19 |
NKTR
Price: $36.04
52 week price:
Payout Ratio Range:
Earnings Per Share: -6.32 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.8 million
Ebitda: 74.9 millionMarket Capitalization: 1.1 billion